Differences in Cytochrome P450 Forms Involved in the Metabolism ofN,N-Dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a Novel Sigma Ligand, in Human Liver and Intestine-Reference-Cited by-同舟云学术

Differences in Cytochrome P450 Forms Involved in the Metabolism ofN,N-Dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a Novel Sigma Ligand, in Human Liver and Intestine

Published:2003-01-01 Issue:1 Volume:31 Page:60-66
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Yamamoto Takahito,Hagima Naoko,Nakamura Masato,Kohno Yoshiro,Nagata Kiyoshi,Yamazoe Yasushi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference40 articles.

1. High performance liquid chromatographic assay for human liver microsomal omeprazole metabolism.;Andersson;J Chromatogr,1993

2. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients.;Anttila;Environ Health Perspect,1992

3. Ketoconazole and sulfaphenazole as the respective selective inhibitors of p4503A and 2C9.;Baldwin;Xenobiotica,1995

4. Diazepam metabolism by rat and human liver in vitro: inhibition by mephenytoin.;Beischlag;Xenobiotica,1992

5. Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma1 ligand, from guinea pig brain

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Oxidation Sites with Order of Occurrence among Multiple Sites for CYP4A-mediated Reactions;Drug Metabolism and Pharmacokinetics;2011

2. Prediction of Drug-Drug Interactions for AUCoral of High Clearance Drug from In Vitro Data: Utilization of a Microtiter Plate Assay and a Dispersion Model;Current Drug Metabolism;2006-02-01

3. Prediction of oral clearance fromin vitrometabolic data using recombinant CYPs: Comparison among well-stirred, parallel-tube, distributed and dispersion models;Xenobiotica;2005-06

4. Enzyme Kinetics for Clinically Relevant CYP Inhibition;Current Drug Metabolism;2005-06-01

5. Presystemic and First-Pass Metabolism;Drug Delivery;2005-05-13